ALG6-CDG in South Africa: genotype-phenotype description of five novel patients

Abstract

ALG6-CDG (formerly named CDG-Ic) (phenotype OMIM 603147, genotype OMIM 604566), is caused by defective endoplasmic reticulum a-1,3-glucosyltransferase (E.C 2.4.1.267) in the N-glycan assembly pathway (Gr€unewald et al. 2000). It is the second most frequent N-glycosylation disorder after PMM2-CDG; some 37 patients have been reported with 21 different ALG6 gene mutations (Haeuptle & Hennet 2009; Al-Owain 2010).We report on the clinical and biochemical findings of five novel Caucasian South African patients. The first patient had a severe neurogastrointestinal presentation. He was compound heterozygous for the known c.998C>T (p.A333V) mutation and the novel c.1338dupA (p.V447SfsX44) mutation. Four more patients, presenting with classical neurological involvement were identified and were compound heterozygous for the known c.257 + 5G>Asplicemutation and the c.680G>A(p.G227E) missense mutation. The patients belong to a semi-isolated Caucasian community that may have originated from European pioneers who colonized South Africa in the seventeenth/ eighteenth centuries.